Stereotactic Ablative Radiation for Oligoprogressive Cancers: Results of the Randomized Phase 2 STOP Trial

Post time 2026-10-22 16:29:13

journal：International Journal of Radiation Oncology*Biology*Physics

Authors：Devin Schellenberg; Zsolt Gabos; Adele Duimering; Brock Debenham; Alysa Fairchild; Fleur Huang; Lindsay S. Rowe; Diane Severin; Meredith E. Giuliani; Andrea Bezjak; Benjamin H. Lok; Srinivas Raman; Peter Chung; Yizhou Zhao; Clement K. Ho; Michael Lock; Alexander V. Louie; Shilo Lefresne; Hannah Carolan; Mitchell Liu; Vivian Yau; Allison Ye; Robert A. Olson; Benjamin Mou; Islam G. Mohamed; David W. Petrik; Maryam Dosani; Howard Pai; Boris Valev; Stewart Gaede; Andrew Warner; David A. Palma

Published date：2025-1-

DOI：10.1016/j.ijrobp.2024.08.031

PDF link：https://www.sciencedirect.com/sc ... 360301624032814/pdf

Article link：https://doi.org/10.1016/j.ijrobp.2024.08.031

Article Source：Elsevier BV。

Remark：

Post time 2026-10-22 16:29:14

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Elsevier] Stereotactic Ablative Radiation for Oligoprogressive Cancers: Results of the Randomized Phase 2 STOP Trial

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Elsevier] Stereotactic Ablative Radiation for Oligoprogressive Cancers: Results of the Randomized Phase 2 STOP Trial Copy

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Elsevier] Stereotactic Ablative Radiation for Oligoprogressive Cancers: Results of the Randomized Phase 2 STOP Trial